Sulfonamides and carbamates of 3-fluoro-4-morpholinoaniline (linezolid intermediate): synthesis, antimicrobial activity and molecular docking study

The precursor compound 3-fluoro-4-morpholinoaniline (7) is an important intermediate of the antibiotic drug linezolid and was synthesized initially by the substitution of morpholine (5) on 1,2-difluoro-4-nitrobenzene (4) under neat conditions, resulting in 4-(2-fluoro-4-nitrophenyl)morpholine (6) fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research on chemical intermediates 2018, Vol.44 (1), p.469-489
Hauptverfasser: Janakiramudu, Dasari Balija, Subba Rao, Devineni, Srikanth, Chilukuru, Madhusudhana, Saddala, Sreenivasa Murthy, Poojary, Nagalakshmidevamma, Mundla, Chalapathi, Ponne Venkata, Naga Raju, Chamarthi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The precursor compound 3-fluoro-4-morpholinoaniline (7) is an important intermediate of the antibiotic drug linezolid and was synthesized initially by the substitution of morpholine (5) on 1,2-difluoro-4-nitrobenzene (4) under neat conditions, resulting in 4-(2-fluoro-4-nitrophenyl)morpholine (6) followed by its nitro group reduction with Fe/NH 4 Cl. A series of new sulfonamides ( 9a–e ) and carbamates ( 11a–e ) have been synthesized in good yields (75–89%) by the reaction of substituted aryl sulfonyl chlorides ( 8a–e ) and substituted aryl/acyclic chloroformates ( 10a–e ) with precursor compound 7 , respectively, for biological interest. Structures of the title products were elucidated by spectroscopic data such as IR, NMR ( 1 H and 13 C NMR) and mass and elemental analyses. The antimicrobial potency of title products was examined by the screening of growth of zone of inhibition against four bacteria and four fungi, and minimum inhibitory concentration (MIC) was also determined. Most of the compounds showed good to potent antimicrobial activity, whereas the title products, 9d and 9e against bacterial strains, and 9a, 9b , 9d and 11a against fungi, exhibited promising activity in the MIC range of 6.25–25.0 µg/mL. The whole biological activity results revealed that the sulfonamide derivatives behaved as potent antifungal agents as compared to the carbamate derivatives. Molecular docking studies of the crystal structure of topoisomerase II gyrase A complexed with natural inhibitor, clorobiocin (1kzn), using the molecular operating environment (MOE) programme were performed in order to predict the affinity and orientation of the synthesized compounds at the active enzyme site. The test compounds showed good binding affinities and formed hydrogen bonds with a surrounding of amino acids at the active sight, whereas compounds 9d (−189.0 kcal/mol) and 11a (−280.3 kcal/mol) exhibited high binding affinities and good agreement with in vitro antimicrobial screening.
ISSN:0922-6168
1568-5675
DOI:10.1007/s11164-017-3114-1